0.5 mg tirzepatide Mounjaro (Tirzepatide) Injection 5 mg/0.5 mL Syringes — Mountainside Medical Lilly launches lower-price weight-loss drug

This article unpacks the evergreening tactics, Indias legal framework, and why 2026 wont herald an immediate generics boom

Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry Medicaid coverage for GLP-1s, both for Type 2 diabetes and obesity, varies widely across the United States

That said, CagriSema is further along the FDA approval pathway at the time of writing

Clinical studies of tirzepatide show that gastrointestinal side effects occur in up to 40% of patients, with nausea being more common than heartburn specifically

Advertised Pricing Accuracy Perfect I didnt find pricing in Willows ads, which means theres no gap between advertised and actual costs